|
1
|
Chang JC: Sepsis and septic shock:
Endothelial molecular pathogenesis associated with vascular
microthrombotic disease. Thromb J. 17(10)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Al Jalbout N, Troncoso R Jr, Evans JD,
Rothman RE and Hinson JS: Biomarkers and molecular diagnostics for
early detection and targeted management of sepsis and septic shock
in the emergency department. J Appl Lab Med. 3:724–729.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hynes-Gay P, Lalla P, Leo M, Merrill-Bell
A, Nicholson M and Villaruel E: Understanding sepsis: From SIRS to
septic shock. Dynamics. 13:17–20. 2002.PubMed/NCBI
|
|
4
|
Weil MH and Shubin H: Proposed
reclassification of shock states with special reference to
distributive defects. Adv Exp Med Biol. 23:13–23. 1971.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Simon TP, Thiele C, Schuerholz T, Fries M,
Stadermann F, Haase G, Amann KU and Marx G: Molecular weight and
molar substitution are more important in HES-induced renal
impairment than concentration after hemorrhagic and septic shock.
Minerva Anestesiol. 81:608–618. 2015.PubMed/NCBI
|
|
6
|
Peng Y, Zhang W, Xu Y, Li L, Yu W, Zeng J,
Ming S, Fang Z, Wang Z and Gao X: Performance of SOFA, qSOFA and
SIRS to predict septic shock after percutaneous nephrolithotomy.
World J Urol. 39:501–510. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee WL: Reply to mehmood: Adrenomedullin:
A double-edged sword in septic shock and heart failure
therapeutics? Am J Respir Crit Care Med. 201(1165)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Izumida T and Imamura T: The impact of
management using fluid response evaluation on renal and respiratory
failure in septic shock. Chest. 158:2706–2707. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Garrido P, Rovira C, Cueto P, Fort-Gallifa
I, Hernandez-Aguilera A, Cabré N, Luciano-Mateo F, Garcia-Heredia
A, Camps J, Joven J, et al: Effect of continuous renal-replacement
therapy on paraoxonase-1-related variables in patients with acute
renal failure caused by septic shock. Clin Biochem. 61:1–6.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Grattard F, Allegra S, Morel J,
Court-Fortune I, Auboyer C, Pozzetto B and Berthelot P: Septic
shock due to legionella pneumophila serogroup 2: Usefulness of
molecular biology for diagnosis, treatment and epidemiological
investigation. Intensive Care Med. 36:1439–1440. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kalra OP and Raizada A: Approach to a
patient with urosepsis. J Glob Infect Dis. 1:57–63. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kim WY and Hong SB: Sepsis and acute
respiratory distress syndrome: Recent update. Tuberc Respir Dis
(Seoul). 79:53–57. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ramachandran G: Gram-positive and
gram-negative bacterial toxins in sepsis: A brief review.
Virulence. 5:213–218. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pranskunas A, Koopmans M, Koetsier PM,
Pilvinis V and Boerma EC: Microcirculatory blood flow as a tool to
select ICU patients eligible for fluid therapy. Intensive Care Med.
39:612–619. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Edul VK, Ferrara G and Dubin A:
Microcirculatory dysfunction in sepsis. Endocr Metab Immune Disord
Drug Targets. 10:235–246. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rodríguez A, Martín-Loeches I and Yébenes
JC: New definition of sepsis and septic shock: What does it give
us? Med Intensiva. 41:38–40. 2017.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
17
|
Pettila V, Jakob SM and Takala J: The new
sepsis/septic shock-3 definition is just not enough-more detailed
research is needed. Acta Anaesthesiol Scand. 60:1344–1346.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
García-Gigorro R, Molina-Collado Z,
Sáez-de la Fuente I, Sanchez-Izquierdo JA and González JC:
Application of the new sepsis-3 definition in a cohort of patients
with severe sepsis and septic shock admitted to intensive care unit
from the emergency department. Med Clin (Barc). 152:13–16.
2019.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
19
|
Vucelić V, Klobučar I, Đuras-Cuculić B,
Grginić A, Prohaska-Potočnik C, Jajić I, Vučičević Z and Degoricija
V: Sepsis and septic shock-an observational study of the incidence,
management, and mortality predictors in a medical intensive care
unit. Croat Med J. 61:429–439. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Daviaud F, Grimaldi D, Dechartres A,
Charpentier J, Geri G, Marin N, Chiche JD, Cariou A, Mira JP and
Pène F: Timing and causes of death in septic shock. Ann Intensive
Care. 5(16)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: Analysis of incidence, outcome, and
associated costs of care. Crit Care Med. 29:1303–1310.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mollura M, Romano S, Mantoan G, Lehman LW
and Barbieri R: Prediction of septic shock onset in ICU by
instantaneous monitoring of vital signs. Annu Int Conf IEEE Eng Med
Biol Soc. 2020:2768–2771. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abe T, Yamakawa K, Ogura H, Kushimoto S,
Saitoh D, Fujishima S, Otomo Y, Kotani J, Umemura Y, Sakamoto Y, et
al: Epidemiology of sepsis and septic shock in intensive care units
between sepsis-2 and sepsis-3 populations: Sepsis prognostication
in intensive care unit and emergency room (SPICE-ICU). J Intensive
Care. 8(44)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jouffroy R, Bloch-Laine E, Maignan M, Le
Borgne P, Marjanovic N, Lafon T, Dehdar S, Thomas L, Michelet P and
Vivien B: Contribution of capillary refilling time and skin
mottling score to predict ICU admission of patients with septic or
haemorrhagic shock admitted to the emergency department: A
TRCMARBSAU study. Turk J Anaesthesiol Reanim. 47:492–495.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nathan N, Sculier JP, Ameye L, Paesmans M,
Bogdan-Dragos G and Meert AP: Sepsis and septic shock definitions
in patients with cancer admitted in ICU. J Intensive Care Med.
36:255–261. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nemes RM, Pop CS, Calagiu D, Dobrin D,
Chetroiu D, Jantea P and Postolache P: Anemia in inflammatory bowel
disease more than an extraintestinal complication. Rev Med Chir Soc
Med Nat Iasi. 120:34–39. 2016.PubMed/NCBI
|
|
27
|
Pavez N, Kattan E, Vera M, Ferri G,
Valenzuela ED, Alegría L, Bravo S, Pairumani R, Santis C, Oviedo V,
et al: Hypoxia-related parameters during septic shock
resuscitation: Pathophysiological determinants and potential
clinical implications. Ann Transl Med. 8(784)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Postolache P, Nemes RM, Petrescu O and
Merisanu IO: Smoking cessation, pulmonary rehabilitation and
quality of life at smokers with COPD. Rev Med Chir Soc Med Nat
Iasi. 119:77–80. 2015.PubMed/NCBI
|
|
29
|
Postolache P, Duceac LD, Vasincu EG and
Nemes RM: Chaos and self-structuring behaviors in lung airways. UPB
Sci Bull Series A. 78:291–298. 2016.
|
|
30
|
Raşcu A, Naghi E, OŢelea MR, NiŢu FM and
Arghir OC: Distinction between mesothelioma and lung adenocarcinoma
based on immunohisthochemistry in a patient with asbestos bodies in
a bronchoalveolar fluid-case report. Rom J Morphol Embryol.
57:1171–1174. 2016.PubMed/NCBI
|
|
31
|
Wang H, Guo S, Wan C, Yang T, Zeng N, Wu
Y, Chen L, Shen Y and Wen F: Tumor necrosis factor-α-308 G/A
polymorphism and risk of sepsis, septic shock, and mortality: An
updated meta-analysis. Oncotarget. 8:94910–94919. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kothari N, Bogra J, Abbas H, Kohli M,
Malik A, Kothari D, Srivastava S and Singh PK: Tumor necrosis
factor gene polymorphism results in high TNF level in sepsis and
septic shock. Cytokine. 61:676–681. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Phumeetham S, Chat-Uthai N,
Manavathongchai M and Viprakasit V: Genetic association study of
tumor necrosis factor-alpha with sepsis and septic shock in thai
pediatric patients. J Pediatr (Rio J). 88:417–422. 2012.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
34
|
Dulhunty JM, Lipman J and Finfer S: Sepsis
Study Investigators for the ANZICS Clinical Trials Group. Does
severe non-infectious SIRS differ from severe sepsis? Results from
a multi-centre Australian and New Zealand intensive care unit
study. Intensive Care Med. 34:1654–1661. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jaramillo-Bustamante JC, Piñeres-Olave BE
and González-Dambrauskas S: SIRS or not SIRS: Is that the
infection? A critical review of the sepsis definition criteria. Bol
Med Hosp Infant Mex. 77:293–302. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shankar-Hari M, Phillips GS, Levy ML,
Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD and
Singer M: Sepsis Definitions Task Force. Developing a new
definition and assessing new clinical criteria for septic shock:
For the third international consensus definitions for sepsis and
septic shock (Sepsis-3). Jama. 315:775–787. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Song J, Cho H, Park DW, Ahn S, Kim JY,
Seok H, Park J and Moon S: The effect of the intelligent sepsis
management system on outcomes among patients with sepsis and septic
shock diagnosed according to the sepsis-3 definition in the
emergency department. J Clin Med. 8(1800)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sterling SA, Puskarich MA, Glass AF,
Guirgis F and Jones AE: The impact of the sepsis-3 septic shock
definition on previously defined septic shock patients. Crit Care
Med. 45:1436–1442. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ronco C: Lipopolysaccharide (LPS) from the
cellular wall of gram-negative bacteria, also known as endotoxin,
is a key molecule in the pathogenesis of sepsis and septic shock
Preface. Blood Purif. 37 (Suppl 1)(S1)2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ishibe Y, Shibata S, Takahashi G, Suzuki
Y, Inoue Y and Endo S: Association of type II secretory
phospholipase A2 and surfactant protein D with the pulmonary
oxygenation potential in patients with septic shock during
polymyxin-B immobilized fiber-direct hemoperfusion. J Clin Apher.
32:302–310. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Charchaflieh J, Wei J, Labaze G, Hou YJ,
Babarsh B, Stutz H, Lee H, Worah S and Zhang M: The role of
complement system in septic shock. Clin Dev Immunol.
2012(407324)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Oettinger W, Berger D and Beger HG: The
clinical significance of prostaglandins and thromboxane as
mediators of septic shock. Klin Wochenschr. 65:61–68.
1987.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ball HA, Cook JA, Wise WC and Halushka PV:
Role of thromboxane, prostaglandins and leukotrienes in endotoxic
and septic shock. Intensive Care Med. 12:116–126. 1986.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tunctan B, Yaghini FA, Estes A and Malik
KU: Prostaglandins inhibit cytochrome P450 4A activity and
contribute to endotoxin-induced hypotension in rats via nitric
oxide production. Arch Pharm Res. 31:856–865. 2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tunctan B, Korkmaz B, Sari AN, Kacan M,
Unsal D, Serin MS, Buharalioglu CK, Sahan-Firat S, Cuez T, Schunck
WH, et al: Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and
gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE
mimetic, against vasodilation, hypotension, tachycardia, and
inflammation in a rat model of septic shock. Nitric Oxide.
33:18–41. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Salvesen O, Reiten MR, Heegaard PM,
Tranulis MA, Espenes A, Skovgaard K and Ersdal C: Activation of
innate immune genes in caprine blood leukocytes after systemic
endotoxin challenge. BMC Vet Res. 12(241)2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Adamik B, Zielinski S, Smiechowicz J and
Kübler A: Endotoxin elimination in patients with septic shock: An
observation study. Arch Immunol Ther Exp (Warsz). 63:475–483.
2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Curuţiu C, Chifiriuc CM and Mitache MM:
Pseudomonas aeruginosa-eukaryotic cell crosstalk: Mediators,
mechanisms and implications for the antimicrobial therapy. Curr Org
Chem. 17:149–154. 2013.
|
|
49
|
Mitache M, Gheorghe I, Totea G, Bleotu C,
Curutiu C, Cochior D, Rusu E and Chifiriuc MC: Biochemical,
virulence and resistance features in bacterial strains recovered
from hospital surfaces after decontamination with quaternary
ammonium compounds, triclosan and iodine disinfectants. Rev Chim
(Bucharest). 68:997–1001. 2017.
|
|
50
|
Elena R, Simona ES, Diana P, Ionela S,
Cojocaru M and Tatiana V: Identification of species of the genus
Candida by analysis of 5.8S rRNA gene. Rom Biotech Lett.
20:10585–10591. 2015.
|
|
51
|
Sârbu I, Vassu T, Chifiriuc MC, Bucur M,
Stoica I, Petrut S, Rusu E, Moldovan H and Pelinescu D: Assessment
the activity of some enzymes and antibiotic substances sensitivity
on pathogenic bacteria species. Rev Chim (Bucharest). 68:3015–3021.
2017.
|
|
52
|
van der Poll T and Opal SM: Host-pathogen
interactions in sepsis. Lancet Infect Dis. 8:32–43. 2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Busani S, Serafini G, Mantovani E,
Venturelli C, Giannella M, Viale P, Mussini C, Cossarizza A and
Girardis M: Mortality in patients with septic shock by multidrug
resistant bacteria: Risk factors and impact of sepsis treatments. J
Intensive Care Med. 34:48–54. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
He XF, Wu GS, Luo PF, Sun Y, Shi SJ and
Xia ZF: Research advances on the molecular mechanisms of vascular
permeability in sepsis. Zhonghua Shao Shang Za Zhi. 36:982–986.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
55
|
Jiménez-Sousa MA, Liu P, Medrano LM,
Fernández-Rodríguez A, Almansa R, Gómez-Sánchez E, Rico L, Lorenzo
M, Fadrique A, Tamayo E and Resino S: Association of CD14 rs2569190
polymorphism with mortality in shock septic patients who underwent
major cardiac or abdominal surgery: A retrospective study. Sci Rep.
8(2698)2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Masson S, Caironi P, Fanizza C, Thomae R,
Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G,
et al: Circulating presepsin (soluble CD14 subtype) as a marker of
host response in patients with severe sepsis or septic shock: Data
from the multicenter, randomized ALBIOS trial. Intensive Care Med.
41:12–20. 2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Luo MC, Zhou SY, Feng DY, Xiao J, Li WY,
Xu CD, Wang HY and Zhou T: Runt-related transcription factor 1
(RUNX1) binds to p50 in macrophages and enhances TLR4-triggered
inflammation and septic shock. J BiolChem. 291:22011–22020.
2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chattopadhyay S, Veleeparambil M, Poddar
D, Abdulkhalek S, Bandyopadhyay SK, Fensterl V and Sen GC: EGFR
kinase activity is required for TLR4 signaling and the septic shock
response. EMBO Rep. 16:1535–1547. 2015.PubMed/NCBI View Article : Google Scholar
|
